CK Regeon
CK Regeon Inc. is a biotechnology-based company aiming to develop First-In-Class drugs with clear MOA.
9 employees · est. 2016 · Seoul, Korea South
Surrozen
Surrozen is a biotechnology company focused on discovering and developing novel regenerative medicines with a focus on unlocking the powerful self-renewal properties of the body through specific control of the Wnt signaling pathway
67 employees · est. 2016 · South San Francisco, United...
Surrozen is the larger of the two.
Side-by-Side Comparison
| Metric | CK Regeon | Surrozen |
|---|---|---|
| Founded | ||
| Founded | 2016 | 2016 |
| Headquarters | ||
| Headquarters | Seoul, Korea South | South San Francisco, United States |
| Employees | ||
| Employees | 9 | 67 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Pharmaceutical | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series B | Unknown |
| Total Funding | ||
| Total Funding | $19.50B | $445.50M |
| Funding Rounds | ||
| Funding Rounds | 2 | 7 |
| Services | ||
| Services | Not tracked yet | Development of Multi-target Antibody Therapeutics, Modulation of Wnt Signaling Pathway |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with Ophthalmic Diseases, Healthcare Providers, Biotechnology and Pharmaceutical Companies |
| Taxonomy | ||
| Taxonomy | Drug Development, Wnt/β-catenin Pathway, Regenerative Medicine, CXXC5, Therapeutic Effects, Tissue Regeneration, Obesity, Diabetes, NASH, Wound Healing, Hair Growth, Alzheimer's Disease, Translational Research, Medical Innovation | Regenerative Medicine, Wnt Signaling Pathway, Tissue-Specific Antibodies, Drug Discovery, Therapeutic Development, Self-Renewal Properties, Tissue Repair, Liver Failure, Disease Modulation, Biological Repair Mechanisms, Intestinal Diseases, Liver Diseases, CNS Disorders, Venture Capital Backed |
| Website | ||
| Website | ckregeon.com | surrozen.com |
About CK Regeon
CK Regeon Inc. is a biotech-based startup founded in October 2016 in South Korea. The company's focus is on developing First-in-Class drugs to address unmet medical needs, with a particular emphasis on the Wnt/β-catenin pathway related to tissue regeneration. Dr. Kang-Yell Choi, the CEO, has a stron...
About Surrozen
Surrozen is a biotechnology company specializing in the discovery and development of innovative regenerative medicines. The company aims to harness the self-renewal properties of the body by precisely controlling the Wnt signaling pathway. Founded in 2016 by a team of five trailblazing scientists,...
We will tell you when either one moves
BounceWatch watches CK Regeon and Surrozen for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at CK Regeon and Surrozen — by email.
Frequently Asked Questions
Compare CK Regeon with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at CK Regeon on 12 Sep 2024, and Surrozen on 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.